Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Express Scripts
AstraZeneca
Dow
McKinsey

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

OXACILLIN SODIUM Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Oxacillin Sodium, and when can generic versions of Oxacillin Sodium launch?

Oxacillin Sodium is a drug marketed by Ani Pharms, Apothecon, Teva, Aurobindo Pharma Ltd, Elkins Sinn, Fresenius Kabi Usa, Hospira Inc, Istituto Bio Ita Spa, Mylan Labs Ltd, Piramal Critical, Sagent Pharms, Sandoz, Watson Labs Inc, and Wockhardt Bio Ag. and is included in twenty-three NDAs.

The generic ingredient in OXACILLIN SODIUM is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Oxacillin Sodium

A generic version of OXACILLIN SODIUM was approved as oxacillin sodium by SAGENT PHARMS on March 30th, 2012.

  Try it Free

Drug patent expirations by year for OXACILLIN SODIUM
Recent Clinical Trials for OXACILLIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Alphacait, LLCPhase 2
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all OXACILLIN SODIUM clinical trials

Pharmacology for OXACILLIN SODIUM
Medical Subject Heading (MeSH) Categories for OXACILLIN SODIUM

US Patents and Regulatory Information for OXACILLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 061490-006 May 9, 1991 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan Labs Ltd OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 091486-002 Aug 25, 2014 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs Inc OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 062856-002 Oct 26, 1988 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs Inc OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 062856-004 Oct 26, 1988 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Wockhardt Bio Ag OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 207147-001 Jul 31, 2017 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Medtronic
Dow
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.